These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8879460)

  • 1. Increases in depression after cholesterol-lowering drug treatment.
    Davidson KW; Reddy S; McGrath P; Zitner D; MacKeen W
    Behav Med; 1996; 22(2):82-4. PubMed ID: 8879460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and cholesterol-lowering chemotherapy: potential influence of smoking cessation, depression history, and dietary change.
    Cinciripini PM
    Behav Med; 1996; 22(2):85-6. PubMed ID: 8879461
    [No Abstract]   [Full Text] [Related]  

  • 3. [A survey on the status of lipid-lowering therapy in 180 hypercholesterolemic patients].
    Cai S; Xia S; Xie H; Yao X; Wang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):378-81; discussion 381-2. PubMed ID: 12482372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering medication and relapse of depression.
    Steffens DC; McQuoid DR; Krishnan KR
    Psychopharmacol Bull; 2003; 37(4):92-8. PubMed ID: 15131520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
    Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral implications of lowering cholesterol levels: a double-blind pilot study.
    Ormiston T; Wolkowitz OM; Reus VI; Manfredi F
    Psychosomatics; 2003; 44(5):412-4. PubMed ID: 12954916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular-weight hydroxypropylmethylcellulose. A cholesterol-lowering agent.
    Dressman JB; Adair CH; Barnett JL; Berardi RR; Dunn-Kucharski VA; Jarvenpaa KM; Parr DD; Sowle CA; Swidan SZ; Tobey SW
    Arch Intern Med; 1993 Jun; 153(11):1345-53. PubMed ID: 8507125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission.
    Vevera J; Fisar Z; Kvasnicka T; Zdenek H; Stárková L; Ceska R; Papezová H
    Psychiatry Res; 2005 Feb; 133(2-3):197-203. PubMed ID: 15740995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms and serum lipid fractions in middle-aged men: physiologic and health behavior links.
    Igna CV; Julkunen J; Vanhanen H; Keskivaara P; Verkasalo M
    Psychosom Med; 2008 Nov; 70(9):960-6. PubMed ID: 18981271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers.
    Conklin SM; Harris JI; Manuck SB; Yao JK; Hibbeln JR; Muldoon MF
    Psychiatry Res; 2007 Jul; 152(1):1-10. PubMed ID: 17383013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simvastatin in CAPD patients with hypercholesterolemia.
    De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
    Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of hypercholesterolemia].
    Schwandt P; Richter WO
    Wien Klin Wochenschr; 1995; 107(18):544-8. PubMed ID: 7483641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
    Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased superoxide anion production by platelets in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Caccese D; Pulcinelli FM; Lenti L; Magnaterra R; Martini F; Lauro R; Violi F
    Thromb Haemost; 2002 May; 87(5):796-801. PubMed ID: 12038779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.